Article
ARID1A Upregulation Predicts Poor Survival in Patients with Liver Cancer
2021-02-02
Abstract excerpt
<title>Abstract</title> <p><bold>Objective:</bold> ARID1A has been identified as a possible biomarker for certain cancers. There is, however, some debate regarding its function in liver cancer. <bold>Methods:</bold> Associations between clinical variables and ARID1A were evaluated. Cox and Kaplan – Meier analysis were used to examine clinicalopathological factors linked to overall survival of patients with liver...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f3f39e76-d3c0-569b-91cd-6f1afed677ce
- DOI
- 10.21203/rs.3.rs-166724/v1
